284 related articles for article (PubMed ID: 16567003)
21. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
[TBL] [Abstract][Full Text] [Related]
22. Mass spectrometric analysis of intact lipooligosaccharide: direct evidence for O-acetylated sialic acids and discovery of O-linked glycine expressed by Campylobacter jejuni.
Dzieciatkowska M; Brochu D; van Belkum A; Heikema AP; Yuki N; Houliston RS; Richards JC; Gilbert M; Li J
Biochemistry; 2007 Dec; 46(50):14704-14. PubMed ID: 18034462
[TBL] [Abstract][Full Text] [Related]
23. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner.
Bax M; Kuijf ML; Heikema AP; van Rijs W; Bruijns SC; García-Vallejo JJ; Crocker PR; Jacobs BC; van Vliet SJ; van Kooyk Y
Infect Immun; 2011 Jul; 79(7):2681-9. PubMed ID: 21502591
[TBL] [Abstract][Full Text] [Related]
24. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
[TBL] [Abstract][Full Text] [Related]
25. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity.
Moran AP; Prendergast MM
J Autoimmun; 2001 May; 16(3):241-56. PubMed ID: 11334489
[TBL] [Abstract][Full Text] [Related]
26. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
Koga M; Gilbert M; Li J; Yuki N
PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522
[TBL] [Abstract][Full Text] [Related]
27. The immunobiology of Guillain-Barré syndromes.
Willison HJ
J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
[TBL] [Abstract][Full Text] [Related]
28. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
Islam Z; Gilbert M; Mohammad QD; Klaij K; Li J; van Rijs W; Tio-Gillen AP; Talukder KA; Willison HJ; van Belkum A; Endtz HP; Jacobs BC
PLoS One; 2012; 7(8):e43976. PubMed ID: 22952833
[TBL] [Abstract][Full Text] [Related]
29. Origin of ganglioside complex antibodies in Guillain-Barré syndrome.
Kuijf ML; Godschalk PC; Gilbert M; Endtz HP; Tio-Gillen AP; Ang CW; van Doorn PA; Jacobs BC
J Neuroimmunol; 2007 Aug; 188(1-2):69-73. PubMed ID: 17604126
[TBL] [Abstract][Full Text] [Related]
30. [Pathogenesis of Guillain-Barré syndrome and Fisher's syndrome: molecular mimicry between antecedent infectious agents and components of nerve tissues].
Yuki N
Rinsho Shinkeigaku; 1995 Dec; 35(12):1373-5. PubMed ID: 8752400
[TBL] [Abstract][Full Text] [Related]
31. Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.
Poly F; Read TD; Chen YH; Monteiro MA; Serichantalergs O; Pootong P; Bodhidatta L; Mason CJ; Rockabrand D; Baqar S; Porter CK; Tribble D; Darsley M; Guerry P
Infect Immun; 2008 Dec; 76(12):5655-67. PubMed ID: 18809665
[TBL] [Abstract][Full Text] [Related]
32. [Comparative study on the role of parent Campylobacter jejuni and galE mutant in inducing experimental peripheral nerve damage].
Shu XM; Cai FC; Zhang XP
Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):256-60. PubMed ID: 15924714
[TBL] [Abstract][Full Text] [Related]
33. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome.
Nachamkin I; Shadomy SV; Moran AP; Cox N; Fitzgerald C; Ung H; Corcoran AT; Iskander JK; Schonberger LB; Chen RT
J Infect Dis; 2008 Jul; 198(2):226-33. PubMed ID: 18522505
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
[TBL] [Abstract][Full Text] [Related]
35. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
Hye JB; Nachamkin I
Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
[No Abstract] [Full Text] [Related]
36. Exchange of lipooligosaccharide synthesis genes creates potential Guillain-Barre syndrome-inducible strains of Campylobacter jejuni.
Phongsisay V; Perera VN; Fry BN
Infect Immun; 2006 Feb; 74(2):1368-72. PubMed ID: 16428786
[TBL] [Abstract][Full Text] [Related]
37. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
Komagamine T; Yuki N
CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
[TBL] [Abstract][Full Text] [Related]
38. Carbohydrate mimicry: a new paradigm of autoimmune diseases.
Yuki N
Curr Opin Immunol; 2005 Dec; 17(6):577-82. PubMed ID: 16229995
[TBL] [Abstract][Full Text] [Related]
39. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
Prendergast MM; Lastovica AJ; Moran AP
Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
[TBL] [Abstract][Full Text] [Related]
40. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.
Heikema AP; Jacobs BC; Horst-Kreft D; Huizinga R; Kuijf ML; Endtz HP; Samsom JN; van Wamel WJ
Clin Microbiol Infect; 2013 Feb; 19(2):E106-12. PubMed ID: 23173866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
